Accessing OTC (Over-the-counter) market data has required time-consuming onboarding, file management, and operational overhead, particularly for quantitative teams, hedge funds, and institutions that depend on deep historical datasets. With Parameta Solutions now delivering OTC data natively through Snowflake’s AI Data Cloud, customers can access governed, analytics ready datasets instantly, without traditional file transfers, infrastructure provisioning, or database engineering.
Our Snowflake Marketplace launch brings trillions of rows of regulated, high‑fidelity market data together in a single cloud‑native environment, spanning interest rate derivatives; money markets; FX; energy and commodities, such as Real-Time Oil data, and Natural Gas Data. Delivered through a zero‑copy architecture, our customers benefit from a modern, cloud native platform where they can bring together market data, internal datasets, analytics tools, and AI/ML workloads in a single, secure environment.
This article highlights eight things to know about how Parameta Solutions delivers OTC market data through Snowflake, and how this approach accelerates analytics workflows, enhances price discovery, strengthens risk management, and enables AI‑driven insights across the enterprise.
1. Data is delivered at truly global scale
Parameta Solutions manages over a trillion rows of OTC financial market data sourced from 2,800+ brokerage desks across Tullett Prebon, ICAP, PVM, and other major liquidity venues. At this scale, traditional file-based delivery simply doesn’t work.
Snowflake provides the distributed, cloud native foundation needed to deliver this data reliably and at speed across all major public cloud providers (AWS, Azure, and Google Cloud) and in every major geographic region. This ensures customers can access Parameta’s datasets with optimised performance, regional compliance alignment, and the flexibility to operate in the cloud ecosystem their infrastructure strategy requires.
2. No Files. No SFTP. No Manual Data Engineering.
Accessing Parameta data via Snowflake means:
- No Excel files or CSV exports
- No SFTP drop-offs
- No ETL jobs or ingestion pipelines to build or maintain
Instead, users receive direct access to live, governed datasets within their Snowflake account. This eliminates data movement, reduces compliance risk, and streamlines analytics workflows from day one.
3. Onboarding in minutes, not months
Historically, delivering large historical datasets could take weeks or even months. With Snowflake’s zero-copy, one-click provisioning, customers can access terabytes of governed data almost instantly, enabling:
- Faster proofs of concept
- Rapid model testing
- Streamlined procurement and evaluation
- Immediate integration with analytics tools
This dramatically improves time to value for both buyside and sell side teams.
4. A Unified, Always Current Source of Truth
Snowflake’s native sharing eliminates the need for duplicate datasets across customers.
Benefits include:
- A single authoritative dataset
- Automatic updates — no redelivery cycles
- No version mismatches
- Consistent, aligned data across teams
This ensures analytics and risk models always operate on the most UpToDate information.
5. Designed for Quantitative and Systematic Teams
Snowflake is particularly well suited to teams who rely on complex data modelling:
- Hedge funds and systematic managers
- Banks’ risk, XVA, and quants
- Research and data science teams
- Enterprise data engineering groups
Customers can query Parameta data using their preferred tools, including Python, SQL, BI tools, and data science notebooks, all directly within Snowflake.
6. Access is only the beginning, understanding is built in
Parameta enhances Snowflake data shares with embedded Python notebooks, providing:
- Prebuilt queries
- Guided onboarding
- Clear examples of common use cases
Instead of being handed a raw database, users get context and guidance from day one, accelerating time to insight.
7. You can ask questions using natural language
Parameta is incorporating Snowflake Cortex to enable natural language interaction with datasets.
This allows users to:
- Ask questions without writing SQL
- Explore complex datasets more intuitively
- Accelerate ad hoc research and discovery
Internally, these capabilities have already reduced customer query response times by 80–95%, with customer facing features rolling out as Snowflake expands availability.
8. Instant Free Trials via Snowflake Marketplace
Parameta is among the first in financial services to use declarative sharing specifically for trials. This means:
- Instant access to live datasets
- No bespoke onboarding work
- No infrastructure required
- Faster evaluation and experimentation
You can request access to free trials here:
- Interest Rate Derivatives
- Interest Rate Volatility
- Money Markets
- Fixed Income
- Inflation Derivatives
- Equity Derivatives
- FX
- Oil
There are many other OTC markets. Search for Parameta Solutions on Snowflake Marketplace to see the full list asset classes available.
Parameta Solutions
Parameta Solutions is the data and analytics division of the TP ICAP Group and the exclusive provider of OTC market data from TP ICAP’s leading brokerage brands, including ICAP, Tullett Prebon and PVM.
We deliver high‑quality OTC market data, indices and analytics across interest rate swaps and options, money markets, FX, and energy and commodities—empowering financial professionals worldwide with trusted insights for the creation of trading strategies, price discovery, pre & post trade analytics, risk management and regulatory compliance.
Contact us for more information on our OTC data products or to request a data sample.
Disclaimer
© 2026 ICAP Information Services Limited (“IISL”). This communication is provided by ICAP Information Services Limited or a member of its group (“Parameta”) and all information contained in or attached hereto (the “Information”) is for information purposes only and is confidential. Access to the Information by anyone other than the intended recipient is unauthorised without Parameta’s prior written approval. The Information may not be not used or disclosed for any purpose without Parameta’s prior written approval, including without limitation, storing, copying, distributing, licensing, selling or displaying the Information, using the Information in an application or to create derived data of any kind, co-mingling the Information with any other data or using the data for any unlawful purpose of for any purpose that would cause it to become a benchmark under any law, regulation or guidance. The Information is not, and should not be construed as, a live price, an offer, bid, recommendation or solicitation in relation to any financial instrument or investment or to participate in any particular trading strategy or constituting financial or investment advice or a financial promotion. The Information does not constitute a public offer under any applicable legislation or an offer to sell or a solicitation of an offer to buy any securities. The Information is not to be relied upon for any purpose whatsoever and is provided “as is” without warranty of any kind, either expressly or by implication, including without limitation as to completeness, timeliness, accuracy, continuity, merchantability or fitness for any particular purpose. All representations and warranties are expressly disclaimed, to the fullest extent possible under applicable law. In no circumstances will Parameta be liable for any indirect or direct loss, or consequential loss or damages including without limitation, loss of business or profits arising from the use of, any inability to use, or any inaccuracy in the Information. Parameta may suspend, withdraw or modify or change the terms of the provision of the Information at any time in its sole discretion, without notice. All rights, including without limitation intellectual property rights, in and to the Information are, and shall remain, the property of IISL or its licensors. Use of, access to or delivery of Parameta’s products and/or services requires a prior written licence from Parameta or its relevant affiliates. The terms of this disclaimer are governed by the laws of England and Wales.
